Target intelligence / Profile preview

Disulfide cross-links in intestinal mucin polymers (MUC2 disulfide bonds)

Target
MUC2 disulfide bonds
Molecular classification
Post-translational modification, Protein-protein interaction site, Structural component
01

Overview

Disulfide cross-links in intestinal mucin polymers, primarily involving the MUC2 glycoprotein, are the fundamental structural elements that allow for the formation of the protective mucus gel in the gut. These covalent bonds form between the cysteine-rich D-domains at the amino- and carboxy-termini of mucin monomers, creating a massive, net-like polymer matrix that provides a physical barrier against pathogens and toxins while lubricating the intestinal wall (Johansson et al., 2011, Nature Reviews Gastroenterology & Hepatology). In healthy states, these cross-links maintain the integrity of the inner 'striated' mucus layer, which is largely impermeable to bacteria. In certain pathological conditions, such as cystic fibrosis or distal intestinal obstruction syndrome (DIOS), the mucus becomes excessively dehydrated and hyper-viscous due to altered cross-linking or concentration, leading to blockages. Conversely, in ulcerative colitis, the mucus layer is often thinned or compromised, potentially due to impaired polymer assembly or excessive degradation. Therapeutic targeting of these disulfide bonds typically involves mucolytic agents like N-acetylcysteine, which act as reducing agents to break the disulfide bridges, thereby liquefying the mucus and facilitating its clearance or penetration by other drugs (Hansson, 2012, Journal of Internal Medicine).

Other names
Mucin-2 disulfide bridgesIntestinal mucus cross-linksMUC2 polymer bondsMucin disulfide linkages
02

Mechanism of action

Reduction of covalent disulfide bonds between mucin monomers into free thiol groups, which breaks down the large polymer network into smaller subunits to decrease mucus viscosity.

03

Biological functions

Mucus gel formationIntestinal barrier maintenanceLubricationPathogen exclusionViscoelasticity regulation
04

Disease associations

Distal intestinal obstruction syndrome (DIOS)Cystic fibrosisUlcerative colitisInflammatory bowel diseaseMeconium ileus
05

Safety considerations

Mucosal barrier disruptionIncreased bacterial translocationGastrointestinal irritationPotential for systemic thiol-disulfide imbalance
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Mucus viscosityMUC2 polymer size distributionFecal mucin contentMucus layer thickness

Beyond the preview

Go deeper on Disulfide cross-links in intestinal mucin polymers (MUC2 disulfide bonds).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disulfide cross-links in intestinal mucin polymers (MUC2 disulfide bonds).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call